BE627619A - - Google Patents

Info

Publication number

BE627619A

BE627619A BE627619DA BE627619A BE 627619 A BE627619 A BE 627619A BE 627619D A BE627619D A BE 627619DA BE 627619 A BE627619 A BE 627619A

Authority

BE

Belgium

Prior art keywords

crusher

discharge

mill

aforementioned

grinding

Prior art date

Links

• Espacenet
• Global Dossier
• Discuss

• 239000000463 material Substances 0.000 claims description 213
• 238000000227 grinding Methods 0.000 claims description 94
• 238000004513 sizing Methods 0.000 claims description 40
• 239000000203 mixture Substances 0.000 claims description 35
• 230000000670 limiting effect Effects 0.000 claims description 28
• 239000000284 extract Substances 0.000 claims description 21
• 238000000034 method Methods 0.000 claims description 20
• 238000006073 displacement reaction Methods 0.000 claims description 16
• 239000007788 liquid Substances 0.000 claims description 11
• 230000008569 process Effects 0.000 claims description 11
• 230000002829 reductive effect Effects 0.000 claims description 10
• 239000003795 chemical substances by application Substances 0.000 claims description 6
• 238000002156 mixing Methods 0.000 claims description 5
• 238000012545 processing Methods 0.000 claims description 5
• 230000009467 reduction Effects 0.000 claims description 5
• 230000000717 retained effect Effects 0.000 claims description 5
• 239000007787 solid Substances 0.000 claims description 3
• 238000001238 wet grinding Methods 0.000 claims description 3
• 206010011878 Deafness Diseases 0.000 claims description 2
• 230000000295 complement effect Effects 0.000 claims description 2
• 235000021189 garnishes Nutrition 0.000 claims description 2
• 239000012530 fluid Substances 0.000 claims 2
• 230000001105 regulatory effect Effects 0.000 claims 2
• 238000012216 screening Methods 0.000 claims 2
• 101100459439 Caenorhabditis elegans nac-2 gene Proteins 0.000 claims 1
• 244000078958 Gardenia weissichii Species 0.000 claims 1
• 241000147041 Guaiacum officinale Species 0.000 claims 1
• FQCKMBLVYCEXJB-MNSAWQCASA-L atorvastatin calcium Chemical compound [Ca+2].C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC([O-])=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1.C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC([O-])=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 FQCKMBLVYCEXJB-MNSAWQCASA-L 0.000 claims 1
• 230000015572 biosynthetic process Effects 0.000 claims 1
• 239000003292 glue Substances 0.000 claims 1
• 229940002661 lipitor Drugs 0.000 claims 1
• 239000011344 liquid material Substances 0.000 claims 1
• 239000002245 particle Substances 0.000 description 33
• 239000000047 product Substances 0.000 description 25
• 230000009471 action Effects 0.000 description 13
• 230000000694 effects Effects 0.000 description 11
• 230000005484 gravity Effects 0.000 description 9
• 230000008901 benefit Effects 0.000 description 8
• 230000036961 partial effect Effects 0.000 description 8
• 238000005096 rolling process Methods 0.000 description 7
• 238000012856 packing Methods 0.000 description 6
• 229910052740 iodine Inorganic materials 0.000 description 5
• 238000004519 manufacturing process Methods 0.000 description 5
• 230000002093 peripheral effect Effects 0.000 description 5
• 238000007599 discharging Methods 0.000 description 4
• 239000011630 iodine Substances 0.000 description 4
• 239000000725 suspension Substances 0.000 description 4
• ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
• 238000005299 abrasion Methods 0.000 description 3
• 239000011362 coarse particle Substances 0.000 description 3
• 238000005192 partition Methods 0.000 description 3
• 239000002994 raw material Substances 0.000 description 3
• 238000000926 separation method Methods 0.000 description 3
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
• 238000009825 accumulation Methods 0.000 description 2
• 238000013459 approach Methods 0.000 description 2
• 230000009286 beneficial effect Effects 0.000 description 2
• 230000008021 deposition Effects 0.000 description 2
• 238000009837 dry grinding Methods 0.000 description 2
• 230000007246 mechanism Effects 0.000 description 2
• 238000003801 milling Methods 0.000 description 2
• 235000007173 Abies balsamea Nutrition 0.000 description 1
• 239000004857 Balsam Substances 0.000 description 1
• 101100394003 Butyrivibrio fibrisolvens end1 gene Proteins 0.000 description 1
• 101150030072 CNTF gene Proteins 0.000 description 1
• VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
• 244000241257 Cucumis melo Species 0.000 description 1
• 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
• 101710200331 Cytochrome b-245 chaperone 1 Proteins 0.000 description 1
• 102100037186 Cytochrome b-245 chaperone 1 Human genes 0.000 description 1
• 101710119396 Cytochrome b-245 chaperone 1 homolog Proteins 0.000 description 1
• 101100536354 Drosophila melanogaster tant gene Proteins 0.000 description 1
• 241001505295 Eros Species 0.000 description 1
• ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 1
• 241000282326 Felis catus Species 0.000 description 1
• 244000018716 Impatiens biflora Species 0.000 description 1
• 241000252067 Megalops atlanticus Species 0.000 description 1
• 101100496106 Mus musculus Clec2f gene Proteins 0.000 description 1
• 241000286209 Phasianidae Species 0.000 description 1
• 244000117054 Rungia klossii Species 0.000 description 1
• 235000002492 Rungia klossii Nutrition 0.000 description 1
• 241000255632 Tabanus atratus Species 0.000 description 1
• 240000008042 Zea mays Species 0.000 description 1
• FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
• 208000027697 autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency Diseases 0.000 description 1
• 238000009412 basement excavation Methods 0.000 description 1
• 210000000988 bone and bone Anatomy 0.000 description 1
• 238000005266 casting Methods 0.000 description 1
• 239000007795 chemical reaction product Substances 0.000 description 1
• 239000003245 coal Substances 0.000 description 1
• 238000010908 decantation Methods 0.000 description 1
• 230000007423 decrease Effects 0.000 description 1
• 230000003247 decreasing effect Effects 0.000 description 1
• 238000009826 distribution Methods 0.000 description 1
• 230000003028 elevating effect Effects 0.000 description 1
• 239000012634 fragment Substances 0.000 description 1
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
• 239000010931 gold Substances 0.000 description 1
• 229910052737 gold Inorganic materials 0.000 description 1
• 229910052500 inorganic mineral Inorganic materials 0.000 description 1
• 238000009413 insulation Methods 0.000 description 1
• 239000013067 intermediate product Substances 0.000 description 1
• 150000002496 iodine Chemical class 0.000 description 1
• 229910052742 iron Inorganic materials 0.000 description 1
• 235000015141 kefir Nutrition 0.000 description 1
• 230000013011 mating Effects 0.000 description 1
• 239000011707 mineral Substances 0.000 description 1
• 210000000056 organ Anatomy 0.000 description 1
• 239000013641 positive control Substances 0.000 description 1
• 230000000750 progressive effect Effects 0.000 description 1
• 238000004064 recycling Methods 0.000 description 1
• 230000002441 reversible effect Effects 0.000 description 1
• 238000007790 scraping Methods 0.000 description 1
• 238000005549 size reduction Methods 0.000 description 1
• 239000002893 slag Substances 0.000 description 1
• 230000035943 smell Effects 0.000 description 1
• 238000003860 storage Methods 0.000 description 1
• 238000012360 testing method Methods 0.000 description 1